US Patent 7326679 Anticancer peptide compositions
Patent 7326679 was granted and assigned to TranXenoGen, Inc. on February, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Alexander Baguisi0
Kathleen M. Hehir0
Nathan H. Sloane0
Paul DiTullio0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+140 characters)
Article
Patent abstract
The invention provides compositions and methods for inhibiting angiogenesis associated with tumors and reducing tumor growth.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07326679 Anticancer peptide compositions US Patent 7326679 Anticancer peptide compositions
Infobox
Patent Number
073266790
Patent Number
73266790
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073266790
Date of Patent
February 5, 2008
0Patent Application Number
109776290
Date Filed
October 29, 2004
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07326679 Anticancer peptide compositions
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07326679
Date of patent
February 5, 2008
Patent application number
10977629
Date Filed
October 29, 2004
Patent primary examiner
Find more entities like US Patent 7326679 Anticancer peptide compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.